Founded in 2004, Sutro Biopharma, Inc has raised over $59M in funding since its inception. Current investors include SV Life Sciences, Alta Partners, Skyline Ventures, and Lilly Ventures. Alta Partners is a leading venture capital firm in life sciences, funding over 120 companies in the industry since 1996. Alta's diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for our companies and our investors. As an important component of Amgen's overall outreach strategy, Amgen Ventures invests in early-stage biotechnology companies focused on discovering and developing human therapeutics. The fund, which focuses primarily on areas of current therapeutic interest to Amgen, offers early-stage companies access to our extensive capabilities while providing us with insight into external research innovations that may pave the way for future collaborations.